Journal of Crohn's & colitisHumansColitisUlcerativeFemaleMale
Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU.
Jordina Llaó, Míriam Mañosa, Eduardo Martín-Arranz, Yamile Zabana, Mercè Navarro-Llavat, Marta Téller, Esther Garcia-Planella, David Busquets, David Monfort, Juan-Ramón Pineda, Ana Gutiérrez, Albert Villoria, Luis Menchén, Guillermo Bastida, Francisco Javier García-Alonso
Published: 202510.1093/ecco-jcc/jjaf182
Abstract
BACKGROUND: Oral corticosteroids remain the treatment of choice for moderately active ulcerative colitis (UC), achieving clinical remission in 30%-60% of patients. OBJECTIVE: To compare the rates of steroid-free clinical-endoscopic remission at weeks…
Preview only. Read the full abstract at the source